Eton Pharmaceuticals Inc. (ETON)
NASDAQ: ETON
· Real-Time Price · USD
17.01
0.31 (1.86%)
At close: Aug 15, 2025, 3:59 PM
17.04
0.18%
After-hours: Aug 15, 2025, 04:10 PM EDT
Eton Pharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -4.13M | -4.58M | -3.82M | -5.48M | -6.69M | 913K | -936K | 2.23M | -234K | -6.35M | -9.02M | -8.89M | -11.94M | -12.4M | -1.96M | -10.68M | -11.09M | -13.8M |
Depreciation & Amortization | 2.65M | 1.91M | 1.17M | 1.09M | 1.01M | 965K | 901K | 878K | 846K | 1.81M | 1.77M | 1.66M | 1.57M | 488K | 462K | 486K | 565K | 644K |
Stock-Based Compensation | 4.8M | 3.54M | 3.17M | 3.13M | 3.14M | 3.09M | 3.14M | 3.27M | 3.49M | 4.01M | 4.22M | 4.2M | 4.25M | 3.79M | 3.38M | 3.29M | 3.01M | 2.88M |
Other Working Capital | 8.56M | 12.21M | 1.41M | 5.29M | 5.7M | 3.09M | 5.46M | 4.67M | 4M | 4.62M | 4.12M | 3.25M | 1.63M | 1.34M | -910K | -1.53M | -741K | -2.13M |
Other Non-Cash Items | 9.99M | 2.61M | 1.15M | 125K | 115K | 88K | 117K | 121K | 122K | 120K | 127K | 134K | 141K | 148K | 148K | 146K | 144K | 130K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -546K | -546K | -546K | -546K | n/a |
Change in Working Capital | -1.08M | 2.06M | -698K | 3.25M | 2.46M | 838K | 3.6M | 2.76M | 2.47M | 2.47M | 7.72M | -230K | 1.59M | 1.31M | -6.21M | 518K | -1.01M | -1.27M |
Operating Cash Flow | 12.24M | 5.53M | 969K | 2.12M | 42K | 5.89M | 6.82M | 9.27M | 6.69M | 2.05M | 4.82M | -3.14M | -4.38M | -7.21M | -4.72M | -6.79M | -8.93M | -11.41M |
Capital Expenditures | -6.26M | -6.26M | -8.15M | -789K | -2.66M | -2.66M | -775K | -12K | -2.01M | -2.77M | -2.79M | -6.03M | -4.03M | -3.27M | -3.26M | -49K | -49K | -46K |
Cash Acquisitions | -30M | -30M | -30M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 700K | 700K | 700K | 700K | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -9.99M | -9.99M | -9.99M | -1.87M | n/a | n/a | n/a | -2.75M | -4.75M | -5.5M | -5.5M | -6M | -4M | -2.55M | -2.55M | 700K | 700K | n/a |
Investing Cash Flow | -38.13M | -38.13M | -40.01M | -2.66M | -2.66M | -2.66M | -775K | -12K | -2.01M | -2.77M | -2.79M | -6.03M | -4.03M | -2.57M | -2.56M | 651K | 651K | -46K |
Debt Repayment | 24.92M | 24.54M | 24.15M | -1.54M | -1.54M | -1.54M | -1.16M | -770K | -385K | n/a | -385K | -385K | -535K | -535K | -150K | -150K | 2.12M | 2.12M |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | -181K | -181K | -181K | -181K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 248K | 248K | 248K | 181K | 181K | 320K | 271K | 189K | 224K | 202K | 251K | 220K | 194K | 438K | 541K | 636K | 670K | 800K |
Financial Cash Flow | 33.58M | 33.37M | 32.59M | -1.27M | -1.26M | -1.29M | -957K | -564K | -161K | 202K | -134K | -165K | -341K | -97K | 391K | 21.51M | 23.81M | 24.24M |
Net Cash Flow | 7.68M | 765K | -6.45M | -1.81M | -3.87M | 1.95M | 5.08M | 8.69M | 4.52M | -521K | 1.9M | -9.33M | -8.76M | -9.88M | -6.89M | 15.38M | 15.53M | 12.78M |
Free Cash Flow | 5.97M | -732K | -7.18M | 1.33M | -2.62M | 3.23M | 6.04M | 9.26M | 4.68M | -723K | 2.03M | -9.17M | -8.41M | -10.49M | -7.98M | -6.83M | -8.98M | -11.46M |